Skip to main

Top Losers

Last updated Jan 12, 2026 at 4:02 PM

Discover today’s top-losing stocks with real-time data to help investors and traders stay informed on the latest market shifts. This data includes the 50 US-listed stocks with the steepest losses, with key financial metrics like daily change, market cap, trading volume, and daily highs and lows.

Invest in stocks and more on Public

Public is an all-in-one investing platform where you can build a multi-asset portfolio that includes everything from stocks and options to bonds, crypto, and a High-Yield Cash Account.

Sign up now
NamePriceChangeMarket CapVolumeAnalyst RatingHigh TodayLow Today
ATRA
Atara Biotherapeutics
$6.13-55.19%98.57M2.73M$6.50$5.58
Trade
NBY
NovaBay Pharmaceuticals
$12.20-36.33%2.42B1.6M$17.39$12.18
LXEO
Lexeo Therapeutics Inc
$7.30-30.74%769.29M2.63M$9.59$6.90
ATEC
Alphatec Hlds
$18.09-20.16%3.37B4.41M$21.51$17.43
STOK
Stoke Therapeutics Inc
$27.16-17.34%1.88B511.29K$27.75$25.21
PRLD
Prelude Therapeutics
$2.19-16.92%148.9M162.6K$2.67$2.18
ANF
Abercrombie & Fitch
$104.10-16.63%5.73B2.96M$104.75$98.80
NUVB
Nuvation Bio
$6.77-15.86%2.77B5.58M$7.70$6.32
XOMA
XOMA
$25.17-15.68%369.64M439.94K$29.45$24.91
OPAD
Offerpad Solutions
$1.86-15.06%80.73M6.49M$1.89$1.77
AZI
Autozi Internet Technology Global Ltd
$2.72-14.88%325.96M199.69K$3.08$2.62
APLS
Apellis Pharma
$23.40-14.29%3.46B1.68M$26.55$22.89
WGS
GeneDx Holdings Corp
$116.52-13.93%3.92B668.31K$133$114.06
KPTI
Karyopharm Therapeutics
$7.48-13.82%158.94M209.6K$8.64$7.05
CVRX
CVRx
$7.01-13.56%212.57M79.53K$8.15$6.96
INGN
Inogen
$6.09-13.37%190.86M283.31K$6.75$6
SMMT
Summit Therapeutics
$17.09-13.19%14.62B3.25M$19.90$16.47
SPRY
ARS Pharmaceuticals Inc
$11.36-13.06%1.3B1.56M$13.15$11.20
AUTL
Autolus Therapeutics
$1.58-12.86%481.72M2.48M$1.79$1.57
DGNX
Diginex Ltd
$2.69-12.83%622.01M880.74K$3.11$2.54
FLYX
flyExclusive Inc
$5.59-12.52%132.65M2.11M$7.20$4.92
CLNN
Clene Nanomedicine
$5.60-12.43%66.09M119.8K$6.68$5.60
MESO
Mesoblast
$18.37-12.36%2.69B227.56K$19.35$18.25
URBN
Urban Outfitters
$71.95-11.78%7.32B1.45M$75.01$70.41
STTK
Shattuck Labs
$4.20-11.57%300.58M220.46K$4.80$4.09
AEVA
Aeva Technologies Inc
$17.65-11.20%1.2B2.3M$19.48$17.46
ZNTL
Zentalis Pharmaceuticals
$3.33-10.92%270.22M3.55M$3.95$3.11
CATX
Perspective Therapeutics Inc
$2.53-10.92%211.12M722.69K$2.89$2.45
BBNX
Beta Bionics Inc
$17.96-10.85%886.66M787.13K$20.31$17.42
SIDU
Sidus Space
$3.58-10.72%261.77M21.29M$4.03$3.43
OESX
Orion Energy Systems
$15.19-10.68%60.03M30.22K$16.95$15.06
BFH
Bread Financial Holdings Inc
$72.01-10.40%3.67B916.54K$73.80$70.06
VICR
Vicor
$127.72-10.25%6.36B374.88K$141.34$125.00
AKBA
Akebia Therapeutics
$1.37-9.87%403.36M2.33M$1.49$1.37
AXTI
AXT
$20.74-9.81%1.28B5.72M$23.30$20.10
CURR
Currenc Group Inc
$1.58-9.79%134.05M88.14K$1.75$1.56
MRNO
Murano Global BV
$1.39-9.73%122.15M101.34K$1.60$1.31
DBGI
Digital Brands Group Inc
$15.36-9.43%138.88M140.3K$17.44$14.80
RENT
Rent the Runway
$8.18-9.37%301.19M61.67K$9.09$8.05
FBIO
Fortress Biotech
$3.90-9.30%133.47M756.09K$4.38$3.89
HYFT
ImmunoPrecise Antibodies Ltd
$2.47-9.19%127.01M1.53M$2.95$2.10
IBIO
iBio
$2.45-9.16%60.72M1.02M$2.68$2.42
ALNY
Alnylam Pharmaceuticals
$361.83-9.15%52.62B1.17M$378.61$356.02
PASG
PASSAGE BIO
$18.06-9.02%61.94M25.46K$19.95$18.05
CAI
CAI
$25.94-9.01%8.05B1.21M$29$25.30
QURE
uniQure
$23.04-9.01%1.56B989.02K$25.11$22.65
NERV
Minerva Neurosciences
$4.06-8.76%192.58M20.66K$4.51$4.03
SRPT
Sarepta Therapeutics
$21.75-8.73%2.5B850.08K$24.05$21.68
GANX
Gain Therapeutics
$2.11-8.66%88.85M790.92K$2.29$2.08
SHMD
SCHMID Group NV
$7.83-8.64%417.26M145.4K$8.75$7.70

*Analyst Ratings available to Premium Members only.

Market data by Xignite. In order to offer the best user experience, certain criteria were applied - Stocks with a market capitalization of less than 50 million, All OTC (over-the-counter) stocks, penny stocks (trading below $1 value), as well as stocks with an average daily volume of less than 10,000 over the past three months or less than 100,000 intraday volume were excluded from the dataset.

Please note that while we strive to provide accurate and up-to-date information, stock prices and other data may fluctuate and should be verified independently. We encourage users to conduct thorough research before making any investment decisions based on the information provided.